|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The Her-2/neu gene and protein in breast cancer 2003 : biomarker and target of therapy 显示文摘 | Ross J S Fletcher J A Linette G P | 2003 | Oncologist2003，8，4： | 1 |
| 2 | Ipilimumab monotherapy in patients with pretreated advanced melanoma:a randomised,double-blind,muhicentre,phase 2, dose-ranging study显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oneol2010，11，2： | 1 |
| 3 | Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma显示文摘 | Linette G P Stadtmauer E A Maus M V | 2013 | Blood2013，122，6： | 1 |
| 4 | Lpilimumab monotherapy in patients with pretreated advanced melanoma:a randomised,double-blind,multicentre,phase 2,dose-ranging study显示文摘 | Wolchok J Neyns B Linette G | | 0，，： | 1 |
| 5 | Ipilimumab monother- apy in patients with pretreated advanced melanoma: a ran- domised, double-blind, multicentre, phase 2, dose-ranging study 显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，2： | 1 |
| 6 | Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, muhieentre, phase 2 ,dose-ranging study 显示文摘 | Wolehok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，2： | 1 |
| 7 | lpilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double - blind, muhicentre, phase 2, dose - ranging study 显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，： | 1 |
| 8 | Targeted therapy in breast cancer: the HER- 2/neu gene and protein显示文摘 | Ross J S Fletcher J A Bloom K J Linette G P Stec J Symmans W F | 2004 | Mol Cell Proteomics2004，3，： | 1 |
| 9 | The Her-2/neu gene and protein in breast cancer 2003:biomarker and target of therapy显示文摘 | Ross J S Fletcher J A Linette G P | 2003 | Oncologist2003，8，4： | 1 |
| 10 | Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity显示文摘 | Linette G P Zhang D Hodi F S et aL | 2005 | Clin Cancer Res2005，11，21： | 1 |
| 11 | Ipilimumab monothera-py in patients with pretreated advanced melanoma: a random-ised ,double-blind,multicentre,phase 2,dose-ranging study显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，2： | 1 |
| 12 | Ipilimumab monothera-py in patients with pretreated advanced melanoma: a random-ised ,double-blind,multicentre,phase 2,dose-ranging study显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，2： | 1 |
| 13 | Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study 显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，2： | 1 |
| 14 | Ipilimumab monotherapy inpatients with pretreated advanced melanoma : a randomised,double-blind ,multicentre, phase 2, dose-ranging study 显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，2： | 1 |
| 15 | The Her-2/neu gene and protein in breast cancer 2003:biomarker and target of therapy显示文摘 | Ross J S Fletcher J A Linette G P | 2003 | Onclogist2003，8，： | 1 |
| 16 | Ipilimumab monotherapyin patients with pretreated advanced melanoma : a randomised,double-blind,multicentre,phase 2,dose-ranging study 显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，2： | 1 |
| 17 | The Her-2/neu gene and protein in breast cancer 2003:biomarker and target of therapy显示文摘 | Ross J S Fletcher J A Linette G P | 2003 | Oncologist2003，8，4： | 1 |
| 18 | Ipilimumab mono- therapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-rang- ing study显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，2： | 1 |
| 19 | Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，2： | 1 |
| 20 | The Her-2/ neu gene and protein in breast cancer 2003 : biomarker and target of therapy显示文摘 | Ross J S Fletcher J A Linette G P | 2003 | Oncologist2003，8，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员